Nicholas Company Inc. Sells 13,175 Shares of The Cooper Companies, Inc. $COO

Nicholas Company Inc. lowered its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 7.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 157,815 shares of the medical device company’s stock after selling 13,175 shares during the quarter. Nicholas Company Inc. owned about 0.08% of Cooper Companies worth $12,935,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also modified their holdings of COO. Wellington Management Group LLP raised its holdings in shares of Cooper Companies by 332.9% during the 3rd quarter. Wellington Management Group LLP now owns 6,184,992 shares of the medical device company’s stock valued at $424,043,000 after purchasing an additional 4,756,178 shares in the last quarter. JANA Partners Management LP bought a new position in Cooper Companies in the 3rd quarter worth $166,917,000. Capital World Investors raised its holdings in Cooper Companies by 25.7% in the 3rd quarter. Capital World Investors now owns 10,551,592 shares of the medical device company’s stock worth $723,417,000 after acquiring an additional 2,159,233 shares during the period. Ameriprise Financial Inc. raised its holdings in Cooper Companies by 98.8% in the 2nd quarter. Ameriprise Financial Inc. now owns 3,388,413 shares of the medical device company’s stock worth $241,120,000 after acquiring an additional 1,683,561 shares during the period. Finally, Manning & Napier Advisors LLC bought a new position in Cooper Companies in the 4th quarter worth $128,985,000. Institutional investors own 24.39% of the company’s stock.

Analysts Set New Price Targets

Several research analysts recently commented on the stock. William Blair upgraded shares of Cooper Companies to a “strong-buy” rating in a report on Friday, January 30th. Rothschild & Co Redburn downgraded shares of Cooper Companies from a “buy” rating to a “neutral” rating and set a $85.00 target price on the stock. in a report on Wednesday, March 4th. Weiss Ratings upgraded shares of Cooper Companies from a “sell (d+)” rating to a “hold (c-)” rating in a report on Monday, January 12th. Wall Street Zen upgraded shares of Cooper Companies from a “hold” rating to a “buy” rating in a report on Saturday, February 28th. Finally, Needham & Company LLC lifted their target price on shares of Cooper Companies from $99.00 to $101.00 and gave the stock a “buy” rating in a report on Friday, March 6th. One analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $90.79.

Cooper Companies Price Performance

Shares of Cooper Companies stock opened at $60.00 on Monday. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.79 and a current ratio of 1.34. The firm’s 50-day simple moving average is $71.18 and its 200-day simple moving average is $76.08. The Cooper Companies, Inc. has a twelve month low of $59.68 and a twelve month high of $89.83. The firm has a market cap of $11.71 billion, a P/E ratio of 29.70, a price-to-earnings-growth ratio of 1.55 and a beta of 0.89.

Cooper Companies (NASDAQ:COO) last issued its earnings results on Thursday, March 5th. The medical device company reported $1.10 earnings per share for the quarter, beating the consensus estimate of $1.03 by $0.07. Cooper Companies had a net margin of 9.67% and a return on equity of 10.34%. The business had revenue of $1.02 billion for the quarter, compared to analyst estimates of $1.02 billion. During the same period in the previous year, the business earned $0.92 EPS. The firm’s revenue was up 6.2% on a year-over-year basis. Cooper Companies has set its Q2 2026 guidance at 4.580-4.660 EPS. As a group, research analysts expect that The Cooper Companies, Inc. will post 4.62 EPS for the current fiscal year.

Cooper Companies Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.